Fredun Pharmaceuticals Market Cap ($288.50M USD)
Fredun Pharmaceuticals Market Cap ($288.50M USD). As of Nov. 19, 2026, Fredun Pharmaceuticals (FREDUN) market capitalisation is ₹2596.48 Cr ($288.50M), with 1.52 Cr shares outstanding at a current price of ₹1708.00 on NSE, ranking 1063 out of 5368 companies by market cap in our screener. Fredun Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock.
Market Cap History of Fredun Pharmaceuticals (Last 10 Years)
FREDUN market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Fredun Pharmaceuticals screener.
End of Year Market Cap History — Fredun Pharmaceuticals
FREDUN year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Review FREDUN PE ratio trends to evaluate earnings-based valuation against sector peers.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹2596.48 Cr
$288.50M USD
|
₹1708.00 | NSE | +8.22% |
| 2025 |
₹2399.31 Cr
$266.59M USD
|
₹1578.30 | BSE | +114.08% |
| 2024 |
₹1120.76 Cr
$124.53M USD
|
₹737.25 | BSE | -15.14% |
| 2023 |
₹1320.66 Cr
$146.74M USD
|
₹868.75 | BSE | -22.45% |
| 2022 |
₹1702.91 Cr
$189.21M USD
|
₹1120.20 | BSE | +32.45% |
| 2021 |
₹1285.70 Cr
$142.86M USD
|
₹845.75 | BSE | +95.21% |
| 2020 |
₹658.62 Cr
$73.18M USD
|
₹433.25 | BSE | +92.30% |
| 2019 |
₹342.50 Cr
$38.06M USD
|
₹225.30 | BSE | -33.17% |
| 2018 |
₹512.46 Cr
$56.94M USD
|
₹337.10 | BSE | +223.20% |
| 2017 |
₹158.56 Cr
$17.62M USD
|
₹104.30 | BSE | +125.51% |
| 2016 |
₹70.31 Cr
$7.81M USD
|
₹46.25 | BSE | - |